HandyTizer has entered into an agreement to distribute the Orbel hand sanitizer applicator throughout North America. The patented Orbel ™ will fill a market void in North America for a readily accessible, simple to use, and highly effective disposable alcohol-based personal sanitizer. The disposable Orbel applicator, filled with alcohol based hand sanitizer, is intuitive in nature as the device attaches to the user's hip and dispenses the ideal amount of sanitizer with a simple swipe across the face of the device. The Orbel solution singlehandedly delivers seamless, convenient and uniform point of care availability of hand sanitizer. As such, hand hygiene compliance rates in healthcare, which are commonly estimated at less than 50 percent, will increase markedly at facilities utilizing the device, significantly offsetting the estimated $33 billion in associated annual costs to the healthcare industry alone.
"To put it in perspective, hospital acquired infections kill two and a half times as many Americans as breast cancer each year and these deaths are known to be largely preventable through better hand hygiene," says Lawrence Alioto, CEO of HandyTizer. "The solution to this deadly problem is an obvious one; have sanitizer conveniently available to practitioners at all times. The Orbel does just that. The Orbel will save lives. While that should be enough, the Orbel will also save the healthcare industry billions of dollars each year. As such, interest in the device is high with both medical suppliers and end users."
"Hospital infections are an enormous problem and a very well understood issue facing our industry," says Dr. Jerome Vener of CV ENT Surgical Group at HCA West Hills, Calif. "I took one look at the Orbel and knew right away that this is the answer."
HandyTizer will also introduce the Orbel to the commercial market for sanitary compliance. In addition to healthcare and emergency services, the Orbel is ideal for addressing the unwanted spread of bacteria in commercial settings including coffee franchises, hotels and casinos, and banks. Penetration into these verticals will expand the overall hand sanitizer market.
"Orbel and Picketts Health have devoted significant time, money and expertise in our effort to develop, patent and commercialize the Orbel," says Mark Minter, CEO of Orbel and Picketts Health. "The product has been refined, tested and is being rolled out worldwide. We are pleased to be working with HandyTizer in the North American market."
Source: HandyTizer LLC
Tackling Health Care-Associated Infections: SHEA’s Bold 10-Year Research Plan to Save Lives
December 12th 2024Discover SHEA's visionary 10-year plan to reduce HAIs by advancing infection prevention strategies, understanding transmission, and improving diagnostic practices for better patient outcomes.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.